Who is eligible for treatment with bimekizumab? Are there any notable exclusion criteria?
Featuring Mark Lebwohl, MD | Senior Clinical Advisor |
Dean for Clinical Therapeutics | Published November 06, 2023
Dean for Clinical Therapeutics
Kimberly and Eric J. Waldman Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY